lifestyle.thedishh.com

Category: PRNewswire

HOTH THERAPEUTICS ACCELERATES HT-001 TRIAL ENROLLMENT WITH NEW CLINICAL SITE AS PATIENT DEMAND INCREASES

February 24, 2026
GoDaddy Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results

February 24, 2026
Arthur J. Gallagher & Co. Announces New Investor Relations Leader

February 24, 2026
Lucid Files Resale Prospectus Supplement

February 24, 2026
Docusign Announces Timing of Fourth Quarter Fiscal 2026 Earnings Conference Call

February 24, 2026
TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results

February 24, 2026
Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference

February 24, 2026
ClearView successfully implements Equisoft’s cloud-based policy administration system

February 24, 2026
Gen to Present at the Morgan Stanley Technology, Media & Telecom Conference

February 24, 2026
Johnson & Johnson seeks FDA approval of IMAAVY® (nipocalimab-aahu) as the first-ever FDA-approved treatment for warm autoimmune hemolytic anemia (wAIHA)

February 24, 2026